University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

A Study of Intranasal ChAdOx1 nCOV-19

Phase 1

Completed

Conditions: Coronavirus

Interventions: Biological: ChAdOx1 nCov-19

First Posted Date: 2021-03-25

Last Posted Date: 2022-10-24

Lead Sponsor: University of Oxford

Target Recruit Count: 42

Registration Number: NCT04816019

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

ePLH Pilot Study: Online Support Parent Groups - ParentChat

Not Applicable

Completed

Conditions: Child Maltreatment
Positive Parenting

Interventions: Behavioral: ParentChat for parents of children ages 2-17

First Posted Date: 2021-03-22

Last Posted Date: 2022-11-02

Lead Sponsor: University of Oxford

Target Recruit Count: 522

Registration Number: NCT04809272

Locations: 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom

Prospective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid Oxygen

Completed

Conditions: Rheumatoid Arthritis
Psoriatic Arthritis

First Posted Date: 2021-03-18

Last Posted Date: 2023-01-26

Lead Sponsor: University of Oxford

Target Recruit Count: 10

Registration Number: NCT04804449

Locations: 🇬🇧
Nuffield Orthopaedic Centre, Oxford, Oxfordshire, United Kingdom

A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in Tanzania

Not Applicable

Completed

Conditions: Malaria
Plasmodium Falciparum

Interventions: Biological: P. falciparum infected erythrocytes

First Posted Date: 2021-03-09

Last Posted Date: 2023-05-24

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT04788862

Locations: 🇹🇿
Ifakara Health Institute, Bagamoyo, Tanzania

Neuroscience of Charles Bonnet Syndrome

Completed

Conditions: Charles Bonnet Syndrome

Interventions: Diagnostic Test: None, neuroimaging

First Posted Date: 2021-03-02

Last Posted Date: 2024-05-09

Lead Sponsor: University of Oxford

Target Recruit Count: 16

Registration Number: NCT04777630

Locations: 🇬🇧
Vision and Eye Research Institute, Cambridge, United Kingdom
🇬🇧
Wellcome Centre for Integrative Neuroimaging, Oxford, United Kingdom

Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers

Phase 1

Conditions: Tuberculosis

Interventions: Biological: BCG Danish

First Posted Date: 2021-03-02

Last Posted Date: 2023-03-07

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT04777721

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Computer Assisted Lessening of Intrusive Memories in the Emergency Department

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Behavioral: Simple cognitive task

First Posted Date: 2021-02-25

Last Posted Date: 2021-02-25

Lead Sponsor: University of Oxford

Target Recruit Count: 14

Registration Number: NCT04769999

Locations: 🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
🇬🇧
Royal Berkshire NHS Foundation Trust, Reading, United Kingdom
🇬🇧
South Central Ambulance Service NHS Foundation Trust, Bicester, United Kingdom

Safety and Immunogenicity of a Candidate RVFV Vaccine (RVF001)

Early Phase 1

Completed

Conditions: Rift Valley Fever

Interventions: Biological: ChAdOx1 RVF

First Posted Date: 2021-02-15

Last Posted Date: 2023-05-19

Lead Sponsor: University of Oxford

Target Recruit Count: 15

Registration Number: NCT04754776

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Rational Use of Personal Protective Equipment During COVID-19 Pandemic

Not Applicable

Completed

Conditions: Personal Protective Equipment
Covid19

Interventions: Other: New PPE
Other: Old PPE

First Posted Date: 2021-01-15

Last Posted Date: 2021-01-15

Lead Sponsor: University of Oxford

Target Recruit Count: 67

Registration Number: NCT04712045

Locations: 🇬🇧
Professor Peter McCulloch, Oxford, Oxfordshire, United Kingdom

Southeast Asia Dose Optimization of Tafenoquine

Phase 4

Recruiting

Conditions: Plasmodium Vivax Malaria

Interventions: Drug: Tafenoquine
Drug: Chloroquine
Drug: Artemether 20 mg-Lumefantrine 120 mg

First Posted Date: 2021-01-12

Last Posted Date: 2024-08-12

Lead Sponsor: University of Oxford

Target Recruit Count: 700

Registration Number: NCT04704999

Locations: 🇱🇦
Lao Oxford Mahosot Hospital Wellcome Trust Research Unit (LOMWRU), Vientiane, Lao People's Democratic Republic
🇻🇳
Oxford University Clinical Research Unit (OUCRU), Binh Phuoc, Vietnam
🇰🇭
Mahidol Oxford Tropical Medicine Research Unit (MORU), Cambodia, Siem Reap, Cambodia

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy